APOLIPOPROTEIN-E AND ALPHA-1 ANTICHYMOTRYPSIN POLYMORPHISM GENOTYPINGIN ALZHEIMERS-DISEASE AND IN DEMENTIA WITH LEWY BODIES - DISTINCTIONSBETWEEN DISEASES
H. Lamb et al., APOLIPOPROTEIN-E AND ALPHA-1 ANTICHYMOTRYPSIN POLYMORPHISM GENOTYPINGIN ALZHEIMERS-DISEASE AND IN DEMENTIA WITH LEWY BODIES - DISTINCTIONSBETWEEN DISEASES, Neurology, 50(2), 1998, pp. 388-391
The possibility of gene interactions in Alzheimer's disease (AD) has b
een suggested by the finding of an association of the AA genotype of t
he alpha-1 antichymotrypsin (AACT) gene and the apolipoprotein E (apoE
) epsilon 4/4 genotype in AD. We tested this possibility by genotyping
a large series of clinically and neuropathologically confirmed cases
of AD and a series of cases with dementia with Lewy bodies (DLB) with
a matched control group for the AACT locus and apoE. ApoE genotyping s
howed the established finding of an increased frequency of the apoE ep
silon 4 allele in AD and in DLB. The AD and DLB groups differed betwee
n each other with a higher epsilon 2 allele frequency and a reduced in
cidence of the epsilon 4/4 genotype in DLB. Differences in the apoE fr
equencies may account for some of the differences between the two dise
ases. No association was found for the AACT A allele in AD or DLB in t
he groups as a whole or when stratified with respect to apoE, with the
exception of a trend showing an increased incidence of the apoE epsil
on 4/4 AACT AA genotype combination in AD patients (chi(2) = 3.18, p =
0.07), although in DLB this was not apparent (chi(2) = 0.0, p = 1.0).
The AACT A allele is not a major risk factor for late-onset AD or DLB
.